New York Cannabis
Market Intelligence Report
After a rocky launch, New York's legal retail footprint more than doubled in 2025 — and sales followed.
Key Decision Summary
With retail locations doubling in 2025, the historic illicit-to-legal customer conversion opportunity is now much more achievable than in the program's first two years.
556 retailers (up from 261) need substantially more product flow than New York's earlier, smaller licensed retail base required.
A doubling of licensed retailers in a single year means vendor relationships built now have room to scale with the market.
New York's massive unlicensed market has been the central risk to legal operators; continued legal retail expansion is the main lever for displacing it.
New York's program finally hit its stride in 2025 — doubling licensed retail locations and posting record sales after a notoriously slow rollout in 2022-2024.
Market Overview
New York legalized adult-use cannabis in March 2021 but did not open its first licensed retail dispensary until December 2022, and the program's early years were defined by a notoriously slow buildout, widespread unlicensed "gray market" competition, and persistent litigation over the Conditional Adult-Use Retail Dispensary (CAURD) licensing process.
2025 marked a clear turning point: licensed retailers more than doubled from 261 to 556, and annual sales reached approximately $1.5 billion, pushing cumulative sales since launch past $2.5 billion.
| Period | Cumulative Sales Since Launch | Confidence |
|---|---|---|
| Early 2024 | ~$1.0B | Official |
| Mid-2025 (500th dispensary milestone) | ~$2.3B | Official |
| Late 2025 / early 2026 (per OCM officials) | ~$2.5B | Official |
At the September 2025 Cannabis Control Board meeting, all provisional CAURD and adult-use licenses were extended through December 31, 2026, giving licensees additional time to secure viable retail locations as proximity and siting guidance continues to be clarified.
State Demographics
New York's population of roughly 20.1 million makes it the fourth-largest U.S. state, with a median household income above the national average. (Official, Census ACS 2024)
Regulatory & Licensing
The New York Office of Cannabis Management (OCM), overseen by the Cannabis Control Board, regulates licensing, compliance, and enforcement for the state's medical and adult-use cannabis markets. After years of slow licensed buildout, 2025 saw retailer counts more than double, helped by extended provisional license deadlines (through December 31, 2026) and continued state grant funding for licensees.
State Incentives & Support Programs
New York's flagship cannabis incentive is its Social and Economic Equity (SEE) licensing priority, paired with direct state grant funding for qualifying dispensary operators.
Priority licensing pathway resulting in 55% of all adult-use licenses statewide being held by SEE-qualified businesses — one of the strongest equity outcomes nationally. (Official.)
52 licensed dispensaries received grants of up to $30,000 each in June 2025 to support startup and operational costs. (Official.)
A state-backed fund providing loans and real estate support to help equity licensees secure and build out retail locations. (Official program; current total disbursement Not Available.)
Supply Chain
New York's cultivator base has had to scale rapidly to keep pace with the 2025 retail buildout, as the licensed retailer count more than doubled in a single year. The state's hemp-converted "Adult-Use Cultivator" licenses (many originating from the state's existing hemp-growing base) supply much of the early flower volume, supplemented by indoor and processor licensees.
Persistent unlicensed retail competition (the so-called "gray market") has historically been a larger supply-side competitive force in New York than in most other adult-use states, given the multi-year gap between legalization (2021) and meaningful licensed retail scale (2025).
Consumer Demand
As licensed retail access expands rapidly, New York consumer purchasing patterns are still normalizing; flower remains the leading category among newly-converted legal-market customers.
| Product Category | Est. Share of Retail Sales | Confidence |
|---|---|---|
| Flower | 37% | Modeled-Estimated |
| Vapor / Concentrates | 28% | Modeled-Estimated |
| Edibles | 18% | Modeled-Estimated |
| Pre-Rolls | 11% | Modeled-Estimated |
| Other | 6% | Modeled-Estimated |
County-Wise Sales
OCM publishes licensee-level data but not an official regional sales ranking; the table below is a modeled estimate based on retail license density and population.
| Region | Est. Sales Rank | Confidence |
|---|---|---|
| New York City (5 boroughs) | #1 | Modeled-Estimated |
| Long Island (Nassau/Suffolk) | #2 | Modeled-Estimated |
| Capital Region (Albany) | #3 | Modeled-Estimated |
| Western NY (Buffalo/Erie County) | #4 | Modeled-Estimated |
Cost-to-Open Benchmarks
Costs vary enormously by region — New York City buildout costs are substantially higher than upstate markets given real estate and security requirements.
| Cost Item | Typical Range | Confidence |
|---|---|---|
| Adult-use retail license application fee | $2,000–$9,000 depending on revenue tier | Official |
| Annual license fee | $1,000–$20,000+ depending on type/tier | Official |
| NYC retail buildout | $300,000–$1,000,000+ | Modeled-Estimated |
Vendor Demand Signal
Vendor demand signal tracks which product and service categories New York operators are actively sourcing this quarter.
Top inbound vendor-interest categories from New York retailers and cultivators this quarter.
Financials & Tax
New York taxes adult-use cannabis through a potency-based wholesale excise tax (varying by product type: flower, concentrate, or edible) plus a 9% state retail excise tax and a 4% local excise tax, in addition to standard sales tax in some jurisdictions.
| Period | Sales | Tax Revenue |
|---|---|---|
| April 2023 – Nov. 2025 (cumulative) | — | ~$341M (state) |
| Since inception (state + local) | — | $360M+ |
| 2025 (calendar year) | ~$1.5B | Not Available (period total) |
Neighboring States — Regional Impact
New York borders four adult-use states and one medical-only state, placing it in a highly integrated regional market with limited net cross-border demand advantage.
Mature adult-use market; comparable legal access limits cross-border pull in either direction.
Adult-use since 2023; limited cross-border effect given comparable access.
Large, mature adult-use market; minimal cross-border pull given NY's own large retail base.
Small adult-use market; negligible cross-border interaction.
No adult-use program; some cross-border demand into southern NY retailers is plausible. (Modeled-Estimated)
Workforce
New York's rapidly expanding licensed retail base (more than doubling in 2025) has driven substantial job growth in retail, cultivation, and processing, though OCM does not publish a single consolidated current statewide employment figure. (Not Available at the official statewide level; figures cited by industry sources vary widely.)
Social Equity
New York's Social and Economic Equity (SEE) program is among the most successful state equity-licensing initiatives in the country, with 55% of all adult-use licenses statewide held by SEE-qualified businesses. The state has paired this with direct grant funding (52 dispensaries received up to $30,000 each in June 2025) and a Social Equity Cannabis Investment Fund for capital access. (Official.)
Illicit Market
New York has historically had one of the largest unlicensed ("gray market") cannabis retail sectors of any adult-use state, a direct consequence of the multi-year gap between 2021 legalization and meaningful 2025 licensed retail scale. The doubling of licensed retailers in 2025 is widely viewed as the most effective tool for displacing this unlicensed market, though no official statewide illicit-market-share figure is published. (Modeled-Estimated; widely discussed in OCM and industry commentary.)
Market Signals & Data Confidence
This report blends official OCM/Comptroller data with modeled estimates where no single official figure exists; sales and cumulative figures vary by reporting date across sources.
| Data Point | Source Type | As-of Date | Confidence | How We Use It |
|---|---|---|---|---|
| Total/Cumulative Cannabis Sales | Government-reported (OCM) / industry media | 2025 / early 2026 | Medium | Headline stat & trend table |
| Tax Revenue | Government (OCM/Comptroller) | Through Nov. 2025 | High | Financials section |
| Retailer/License Counts | Government (OCM) | End of 2025 | High | Regulatory section |
| Equity Licensing Share | Government (OCM) | 2025 | High | Equity section |
| Population / Income / Age | Government (Census ACS) | 2024 | High | Demographics section |
| Product Category Mix | Industry research | 2025 | Low | Consumer demand framing |
Scenario Outlook & Market Opportunity Snapshot
| Scenario | Key Driver | Est. 2027 Trajectory |
|---|---|---|
| Bear | Retail buildout stalls again; gray market resurges | Flat to -5% vs. 2025 |
| Base | Retail buildout continues at a moderate pace | +10% to +20% vs. 2025 |
| Bull | Retail count approaches population-adjusted parity with mature states | +25%+ vs. 2025 |
New York scores at the top of this report set on raw market size potential. The main risks are continued retail buildout execution and ongoing licensing litigation, both of which have slowed progress before.
Outlook & Next Steps
Retailer counts doubled and sales hit a record — the clearest evidence yet that the program is overcoming its slow start.
Even at 556 retailers, New York remains under-retailed relative to its 20.1 million population compared to mature markets.
New York's gray market remains a meaningful competitive force; continued licensed expansion is the primary lever to address it.
55% SEE license share is among the strongest in the nation and likely to remain a defining feature of the market structure.
What's Free vs. What's a CannBus Membership
Included in This Free Report
- Key Takeaways & Decision Summary
- Market Overview, Demographics, Regulatory & Licensing
- State Incentives, Supply Chain, Consumer Demand
- Regional Sales Estimates (modeled)
- Financials, Neighbors, Workforce, Equity, Illicit Market
- Market Signals, Scenario Outlook, Outlook & Next Steps
Unlocked with Premium / Elite
- Full Cost-to-Open Benchmarks
- Vendor Demand Signal with verified shortlists
- Downloadable data appendix (CSV)
- Priority alerts on OCM regulatory changes
- Direct introductions to vetted vendors
Watch 2026 for whether the buildout pace continues and licensed retail begins meaningfully displacing the state's large unlicensed market.
Sources & Methodology
This report compiles data from the New York Office of Cannabis Management, the NY State Comptroller, federal demographic sources, and reputable industry and policy media. Figures on cumulative sales and dispensary counts vary somewhat across sources depending on the as-of date; we have noted ranges where sources disagree.
Primary Sources
- New York Office of Cannabis Management (OCM) — State regulator; licensing data, sales statistics, press releases
- NY State Comptroller — Adult-Use Cannabis Tax Revenue Report — Tax revenue and retail dispensary statistics
- Marijuana Moment — Policy and sales milestone reporting
- MJBizDaily — New York 2025 Market Coverage — Retail expansion and sales record reporting
- U.S. Census Bureau — ACS 2024 — Population, income, and age demographics